vTv Therapeutics Inc. Class A Common Stock (VTVT) is a publicly traded Healthcare sector company. As of May 21, 2026, VTVT trades at $36.62 with a market cap of $139.78M and a P/E ratio of 0.00. VTVT moved -0.66% today. Year to date, VTVT is -13.64%; over the trailing twelve months it is +68.51%. Its 52-week range spans $12.62 to $44.00. Analyst consensus is strong buy with an average price target of $53.00. Rallies surfaces VTVT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
VTVT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VTVT recently traded at $36.62. Market cap is $139.78M. P/E ratio is 0.00. Revenue is $36.84M.
| Metric | Value |
|---|---|
| Price | $36.62 |
| Market Cap | $139.78M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.00 |
| 52-Week Low | $12.62 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $36.84M |
| Net Income | $-729.00K |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-31.08M | $0.00 |
| 2024 | $1.02M | $-22.70M | $0.00 |
| 2023 | $0 | $-25.97M | $0.00 |
| 2022 | $2.02M | $-25.07M | $0.00 |
6 analysts cover VTVT: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $53.00.